In this study, SHOX2 and RASSF1A gene methylation were utilized to diagnose early lung adenocarcinoma, while surgical tissue samples were employed to mitigate the potential impact of sampling variability. This evidence concerns the gene SHOX2 and lung adenocarcinoma.